+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Nanoemulsions - Global Strategic Business Report

  • PDF Icon

    Report

  • 193 Pages
  • November 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5140632
The global market for Nanoemulsions was estimated at US$12.1 Billion in 2023 and is projected to reach US$20.6 Billion by 2030, growing at a CAGR of 7.8% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

What Are Nanoemulsions, and Why Are They So Crucial in Modern Applications?

Nanoemulsions are submicron-sized emulsions with droplet sizes typically ranging from 20 to 200 nanometers. These emulsions consist of two immiscible liquids, where one liquid is dispersed in the other, stabilized by surfactants or emulsifiers. They offer enhanced stability, improved bioavailability, and high solubility for active ingredients, making them ideal for a variety of industries, including pharmaceuticals, cosmetics, food and beverages, and agrochemicals. Nanoemulsions are commonly used for delivering hydrophobic drugs, cosmetic ingredients, and nutrients, offering efficient encapsulation and sustained release properties.

The importance of nanoemulsions lies in their ability to enhance the effectiveness of formulations across diverse applications. In pharmaceuticals, they improve drug delivery by increasing the solubility and absorption of poorly water-soluble drugs, thereby enhancing therapeutic outcomes. In cosmetics, nanoemulsions are used to improve the penetration of active ingredients into the skin, leading to better product performance. Similarly, in the food and beverage industry, nanoemulsions are utilized to encapsulate flavors, nutrients, and oils, enhancing their stability and bioavailability. As industries seek better ways to deliver active compounds efficiently and consistently, nanoemulsions have become a critical tool for innovation in product development and consumer applications.

How Are Technological Advancements Shaping the Nanoemulsions Market?

Technological advancements have significantly improved the formulation, stability, and scalability of nanoemulsions, driving innovation across various sectors. One of the major developments is the use of high-energy methods, such as high-pressure homogenization, microfluidization, and ultrasonication, to create nanoemulsions with uniform droplet sizes. These techniques provide better control over droplet distribution, resulting in more stable emulsions with improved shelf life. High-pressure homogenization, for instance, involves forcing the emulsion through a narrow gap at high pressure, breaking down droplets into nanometer sizes, which is particularly useful in drug delivery and cosmetics formulations.

The development of low-energy emulsification methods has also contributed to the growth of nanoemulsions. Techniques like phase inversion temperature (PIT) and spontaneous emulsification require less energy and can produce nanoemulsions at lower costs. These methods are advantageous for the food and beverage industry, where cost-effectiveness and scalability are essential. Low-energy methods are also more suitable for sensitive compounds, such as vitamins and bioactive compounds, preserving their functionality during the emulsification process.

Advancements in emulsifiers and surfactants have further enhanced the stability and performance of nanoemulsions. Natural emulsifiers, such as proteins, polysaccharides, and phospholipids, have gained popularity due to their biocompatibility and reduced toxicity. The use of bio-based emulsifiers aligns with consumer preferences for clean-label products in food, cosmetics, and personal care. Additionally, the development of smart nanoemulsions that respond to external stimuli like pH, temperature, or light has expanded the functionality of these systems, enabling controlled release and targeted delivery of active ingredients. These innovations not only improve the effectiveness of nanoemulsions but also support broader trends toward safer, more efficient, and sustainable formulations in various industries.

What Are the Emerging Applications of Nanoemulsions Across Different Sectors?

Nanoemulsions are finding expanding applications across diverse sectors, driven by the need for better delivery systems, enhanced bioavailability, and improved stability. In the pharmaceutical sector, nanoemulsions are widely used for oral, topical, and parenteral drug delivery. They enhance the solubility and absorption of poorly water-soluble drugs, leading to increased bioavailability and faster therapeutic action. Nanoemulsions are also used in vaccines and cancer therapies, where they improve the stability of active ingredients and enable targeted delivery, minimizing side effects and enhancing treatment efficacy.

In the cosmetics and personal care sector, nanoemulsions are employed in skincare products, hair care formulations, and anti-aging treatments. They enhance the penetration of active ingredients into the skin, resulting in better hydration, improved texture, and increased efficacy of products like serums, moisturizers, and sunscreens. Nanoemulsions offer a non-greasy, lightweight feel, which is desirable in cosmetic formulations, making them popular in high-performance skincare products.

In the food and beverage industry, nanoemulsions are used to encapsulate flavors, vitamins, and nutraceuticals, improving their dispersion, stability, and bioavailability. They enhance the taste, texture, and nutritional value of food products, while also enabling the development of low-fat and low-calorie formulations by increasing the solubility of oils and fats. Nanoemulsions are also used in beverages to stabilize functional ingredients, such as omega-3 fatty acids, antioxidants, and plant extracts, allowing manufacturers to develop healthier, fortified drinks with longer shelf lives.

In the agrochemical sector, nanoemulsions are used to deliver pesticides, herbicides, and fertilizers more effectively. They improve the dispersion and absorption of active ingredients, reducing the required doses and minimizing environmental impact. Nanoemulsions facilitate better adherence to plant surfaces, enhancing the efficacy of crop protection agents and supporting sustainable agricultural practices. The expanding applications of nanoemulsions across these sectors highlight their critical role in enhancing product performance, safety, and consumer satisfaction.

What Drives Growth in the Nanoemulsions Market?

The growth in the nanoemulsions market is driven by several factors, including increasing demand for improved drug delivery systems, rising consumer interest in functional foods and cosmetics, and advancements in emulsification technologies. One of the primary growth drivers is the growing need for effective drug delivery systems in the pharmaceutical industry. As the number of poorly water-soluble drugs increases, pharmaceutical companies are seeking advanced formulations that improve solubility, stability, and bioavailability. Nanoemulsions offer a viable solution, enabling faster absorption, targeted delivery, and reduced dosage, which enhance patient outcomes and support pharmaceutical innovation.

The rising consumer demand for functional foods, nutraceuticals, and clean-label cosmetics has further fueled the adoption of nanoemulsions. Consumers are increasingly seeking products that offer enhanced nutritional benefits, better skin absorption, and natural ingredients. Nanoemulsions enable manufacturers to deliver active ingredients more effectively, supporting claims of improved performance in functional foods, dietary supplements, and skincare products. This aligns with consumer trends toward health and wellness, driving demand for fortified foods, anti-aging skincare, and plant-based formulations.

Advancements in emulsification technologies and equipment have also contributed to market growth. High-energy methods like high-pressure homogenization and ultrasonication, combined with the development of novel emulsifiers, have improved the stability, scalability, and cost-effectiveness of nanoemulsions. These innovations have made it easier for manufacturers to incorporate nanoemulsions into their product lines, supporting diverse applications across pharmaceuticals, cosmetics, and food processing.

Regulatory approvals and guidelines for nanoemulsions in pharmaceuticals and food products have further supported market growth. As regulatory bodies recognize the safety and efficacy of nanoemulsions, manufacturers have gained confidence in developing and commercializing new products. The increased focus on sustainable and bio-based emulsifiers has also driven demand for eco-friendly nanoemulsion formulations, particularly in clean-label food and cosmetic products.

With ongoing innovations in emulsification methods, ingredient compatibility, and personalized delivery systems, the nanoemulsions market is poised for robust growth. These trends, combined with increasing demand for improved delivery systems, enhanced bioavailability, and sustainable formulations, make nanoemulsions a vital component of modern product development strategies across pharmaceuticals, food and beverages, cosmetics, and agriculture.

Scope of the Study

The report analyzes the Nanoemulsions market, presented in terms of market value (US$ Million). The analysis covers the key segments and geographic regions outlined below.

Segments

Application (Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials, Vasodilators); Route of Administration (Topical, Oral, Parenteral, Nasal)

Geographic Regions/Countries

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Topical Administration segment, which is expected to reach US$4.2 Billion by 2030 with a CAGR of a 7.4%. The Oral Administration segment is also set to grow at 8.0% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, estimated at $3.3 Billion in 2023, and China, forecasted to grow at an impressive 7.3% CAGR to reach $3.2 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Nanoemulsions Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Nanoemulsions Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Nanoemulsions Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players in the Global Nanoemulsions Market such as Ascendia Pharmaceuticals, Covaris, LLC, Creative Biolabs, Genizer LLC, IDEX Material Processing Technologies and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the 43 companies featured in this Global Nanoemulsions Market report include:

  • Ascendia Pharmaceuticals
  • Covaris, LLC
  • Creative Biolabs
  • Genizer LLC
  • IDEX Material Processing Technologies
  • Industrial Sonomechanics
  • LATITUDE Pharmaceuticals Inc.
  • Owen Biosciences, Inc
  • Qsonica L.L.C
  • Taiwan Liposome Company, Ltd.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Nanoemulsions - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Rising Demand for Enhanced Bioavailability Drives Adoption of Nanoemulsions
  • Expanding Applications in Pharmaceuticals Propel Market Growth
  • Growing Focus on Cosmetic Formulations Sets the Stage for Nanoemulsion Adoption
  • Increasing Use in Food and Beverages Strengthens Market Position
  • Growing Role in Nutraceuticals Expands Addressable Market
  • Expanding Applications in CBD-based Products Bodes Well for Market Demand
  • Use in Antimicrobial Agents Generates Market Opportunities
  • Increasing Focus on Functional Foods Drives Nanoemulsion Adoption
  • Rising Use in Oncology Drug Formulation Propels Market Growth
  • Strong Demand in Veterinary Pharmaceuticals Expands Application Scope
  • Strategic Marketing of Nanoemulsified Supplements Enhances Market Potential
  • Growth in Skin Care Products Drives Demand for Nanoemulsion Formulations
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Nanoemulsions Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • Table 2: World Recent Past, Current & Future Analysis for Nanoemulsions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 3: World 7-Year Perspective for Nanoemulsions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
  • Table 4: World Recent Past, Current & Future Analysis for Topical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 5: World 7-Year Perspective for Topical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 6: World Recent Past, Current & Future Analysis for Oral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 7: World 7-Year Perspective for Oral by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 8: World Recent Past, Current & Future Analysis for Parenteral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 9: World 7-Year Perspective for Parenteral by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 10: World Recent Past, Current & Future Analysis for Nasal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 11: World 7-Year Perspective for Nasal by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 12: World Recent Past, Current & Future Analysis for Steroids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 13: World 7-Year Perspective for Steroids by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 14: World Recent Past, Current & Future Analysis for Anesthetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 15: World 7-Year Perspective for Anesthetics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 16: World Recent Past, Current & Future Analysis for NSAIDs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 17: World 7-Year Perspective for NSAIDs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 18: World Recent Past, Current & Future Analysis for Immunosuppressant by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 19: World 7-Year Perspective for Immunosuppressant by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 20: World Recent Past, Current & Future Analysis for Antiretroviral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 21: World 7-Year Perspective for Antiretroviral by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 22: World Recent Past, Current & Future Analysis for Antimicrobials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 23: World 7-Year Perspective for Antimicrobials by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 24: World Recent Past, Current & Future Analysis for Vasodilators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 25: World 7-Year Perspective for Vasodilators by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Nanoemulsions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • Table 26: USA Recent Past, Current & Future Analysis for Nanoemulsions by Route Of Administration - Topical, Oral, Parenteral and Nasal - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 27: USA 7-Year Perspective for Nanoemulsions by Route Of Administration - Percentage Breakdown of Value Sales for Topical, Oral, Parenteral and Nasal for the Years 2024 & 2030
  • Table 28: USA Recent Past, Current & Future Analysis for Nanoemulsions by Application - Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 29: USA 7-Year Perspective for Nanoemulsions by Application - Percentage Breakdown of Value Sales for Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators for the Years 2024 & 2030
CANADA
  • Table 30: Canada Recent Past, Current & Future Analysis for Nanoemulsions by Route Of Administration - Topical, Oral, Parenteral and Nasal - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 31: Canada 7-Year Perspective for Nanoemulsions by Route Of Administration - Percentage Breakdown of Value Sales for Topical, Oral, Parenteral and Nasal for the Years 2024 & 2030
  • Table 32: Canada Recent Past, Current & Future Analysis for Nanoemulsions by Application - Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 33: Canada 7-Year Perspective for Nanoemulsions by Application - Percentage Breakdown of Value Sales for Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators for the Years 2024 & 2030
JAPAN
  • Nanoemulsions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • Table 34: Japan Recent Past, Current & Future Analysis for Nanoemulsions by Route Of Administration - Topical, Oral, Parenteral and Nasal - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 35: Japan 7-Year Perspective for Nanoemulsions by Route Of Administration - Percentage Breakdown of Value Sales for Topical, Oral, Parenteral and Nasal for the Years 2024 & 2030
  • Table 36: Japan Recent Past, Current & Future Analysis for Nanoemulsions by Application - Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 37: Japan 7-Year Perspective for Nanoemulsions by Application - Percentage Breakdown of Value Sales for Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators for the Years 2024 & 2030
CHINA
  • Nanoemulsions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • Table 38: China Recent Past, Current & Future Analysis for Nanoemulsions by Route Of Administration - Topical, Oral, Parenteral and Nasal - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 39: China 7-Year Perspective for Nanoemulsions by Route Of Administration - Percentage Breakdown of Value Sales for Topical, Oral, Parenteral and Nasal for the Years 2024 & 2030
  • Table 40: China Recent Past, Current & Future Analysis for Nanoemulsions by Application - Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 41: China 7-Year Perspective for Nanoemulsions by Application - Percentage Breakdown of Value Sales for Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators for the Years 2024 & 2030
EUROPE
  • Nanoemulsions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • Table 42: Europe Recent Past, Current & Future Analysis for Nanoemulsions by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 43: Europe 7-Year Perspective for Nanoemulsions by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2024 & 2030
  • Table 44: Europe Recent Past, Current & Future Analysis for Nanoemulsions by Route Of Administration - Topical, Oral, Parenteral and Nasal - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 45: Europe 7-Year Perspective for Nanoemulsions by Route Of Administration - Percentage Breakdown of Value Sales for Topical, Oral, Parenteral and Nasal for the Years 2024 & 2030
  • Table 46: Europe Recent Past, Current & Future Analysis for Nanoemulsions by Application - Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 47: Europe 7-Year Perspective for Nanoemulsions by Application - Percentage Breakdown of Value Sales for Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators for the Years 2024 & 2030
FRANCE
  • Nanoemulsions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • Table 48: France Recent Past, Current & Future Analysis for Nanoemulsions by Route Of Administration - Topical, Oral, Parenteral and Nasal - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 49: France 7-Year Perspective for Nanoemulsions by Route Of Administration - Percentage Breakdown of Value Sales for Topical, Oral, Parenteral and Nasal for the Years 2024 & 2030
  • Table 50: France Recent Past, Current & Future Analysis for Nanoemulsions by Application - Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 51: France 7-Year Perspective for Nanoemulsions by Application - Percentage Breakdown of Value Sales for Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators for the Years 2024 & 2030
GERMANY
  • Nanoemulsions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • Table 52: Germany Recent Past, Current & Future Analysis for Nanoemulsions by Route Of Administration - Topical, Oral, Parenteral and Nasal - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 53: Germany 7-Year Perspective for Nanoemulsions by Route Of Administration - Percentage Breakdown of Value Sales for Topical, Oral, Parenteral and Nasal for the Years 2024 & 2030
  • Table 54: Germany Recent Past, Current & Future Analysis for Nanoemulsions by Application - Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 55: Germany 7-Year Perspective for Nanoemulsions by Application - Percentage Breakdown of Value Sales for Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators for the Years 2024 & 2030
ITALY
  • Table 56: Italy Recent Past, Current & Future Analysis for Nanoemulsions by Route Of Administration - Topical, Oral, Parenteral and Nasal - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 57: Italy 7-Year Perspective for Nanoemulsions by Route Of Administration - Percentage Breakdown of Value Sales for Topical, Oral, Parenteral and Nasal for the Years 2024 & 2030
  • Table 58: Italy Recent Past, Current & Future Analysis for Nanoemulsions by Application - Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 59: Italy 7-Year Perspective for Nanoemulsions by Application - Percentage Breakdown of Value Sales for Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators for the Years 2024 & 2030
UNITED KINGDOM
  • Nanoemulsions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • Table 60: UK Recent Past, Current & Future Analysis for Nanoemulsions by Route Of Administration - Topical, Oral, Parenteral and Nasal - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 61: UK 7-Year Perspective for Nanoemulsions by Route Of Administration - Percentage Breakdown of Value Sales for Topical, Oral, Parenteral and Nasal for the Years 2024 & 2030
  • Table 62: UK Recent Past, Current & Future Analysis for Nanoemulsions by Application - Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 63: UK 7-Year Perspective for Nanoemulsions by Application - Percentage Breakdown of Value Sales for Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators for the Years 2024 & 2030
REST OF EUROPE
  • Table 64: Rest of Europe Recent Past, Current & Future Analysis for Nanoemulsions by Route Of Administration - Topical, Oral, Parenteral and Nasal - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 65: Rest of Europe 7-Year Perspective for Nanoemulsions by Route Of Administration - Percentage Breakdown of Value Sales for Topical, Oral, Parenteral and Nasal for the Years 2024 & 2030
  • Table 66: Rest of Europe Recent Past, Current & Future Analysis for Nanoemulsions by Application - Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 67: Rest of Europe 7-Year Perspective for Nanoemulsions by Application - Percentage Breakdown of Value Sales for Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators for the Years 2024 & 2030
ASIA-PACIFIC
  • Nanoemulsions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • Table 68: Asia-Pacific Recent Past, Current & Future Analysis for Nanoemulsions by Route Of Administration - Topical, Oral, Parenteral and Nasal - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 69: Asia-Pacific 7-Year Perspective for Nanoemulsions by Route Of Administration - Percentage Breakdown of Value Sales for Topical, Oral, Parenteral and Nasal for the Years 2024 & 2030
  • Table 70: Asia-Pacific Recent Past, Current & Future Analysis for Nanoemulsions by Application - Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 71: Asia-Pacific 7-Year Perspective for Nanoemulsions by Application - Percentage Breakdown of Value Sales for Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators for the Years 2024 & 2030
REST OF WORLD
  • Table 72: Rest of World Recent Past, Current & Future Analysis for Nanoemulsions by Route Of Administration - Topical, Oral, Parenteral and Nasal - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 73: Rest of World 7-Year Perspective for Nanoemulsions by Route Of Administration - Percentage Breakdown of Value Sales for Topical, Oral, Parenteral and Nasal for the Years 2024 & 2030
  • Table 74: Rest of World Recent Past, Current & Future Analysis for Nanoemulsions by Application - Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 75: Rest of World 7-Year Perspective for Nanoemulsions by Application - Percentage Breakdown of Value Sales for Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators for the Years 2024 & 2030
IV. COMPETITION

Companies Mentioned

  • Ascendia Pharmaceuticals
  • Covaris, LLC
  • Creative Biolabs
  • Genizer LLC
  • IDEX Material Processing Technologies
  • Industrial Sonomechanics
  • LATITUDE Pharmaceuticals Inc.
  • Owen Biosciences, Inc
  • Qsonica L.L.C
  • Taiwan Liposome Company, Ltd.

Table Information